REFERENCES
- Roebuck DJ, Aronson D, Clapuyt P, 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediar Radiol. 2007;37:123–132.
- Perilongo G, Maibach R, Shafford E. Cisplatin versus cislatin plus doxorubicin for standard-risk hepatoblastoma. N Engl J Med. 2009;361:1662–1670.
- van Hoff J, Grier HE, Douglass EC, Etoposide, ifosfamide, and cirsplatin therapy for refractory childhood solid tumors. Response and toxicity. Cancer. 1995;75:2966-2970.
- Zsíros J, Brugières L, Brock P, Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma—a phase II trial of the childhood liver tumour strategy group(SIOPEL). Eur J Cancer. 2012;48:3456–3464.
- Begemann M, Trippett TM, Lis E, Brain metastases in hepatoblastoma. Pediatr Neurol. 2004;30:295–297.